Showing 301-310 of 1097 results for "".
Let’s Talk About Plastic Surgery
https://modernaesthetics.com/ma-podcasts/the-modern-aesthetics-podcast/lets-talk-about-plastic-surgery/33933/Once plastic surgery was only discussed in hushed tones and behind closed doors, but times are changing. Today’s plastic surgery patients are eager to talk about what they have had done and by whom. Many even share their before and afters on social media. New York City plastic surgeon Ryan NeinstMATV News Extra: A Q&A with Dr. Theda Kontis, AAFPRS President
https://modernaesthetics.com/series/matv-news/matv-news-extra-a-qa-with-dr-theda-kontis-aafprs-president/33711/Theda C. Kontis, MD, FACS the second woman to serves as American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS) president, recently sat down with MATV News to discuss her new role and her goals, including continuing to move the academy and foundation forward by further increasing tranMATV News: DREAM Initiative’s Forces of Beauty Report; AAFPRS Medical Mission Trip to Ukraine; Galderma’s Investigational Neurotoxin Gets High Marks
https://modernaesthetics.com/series/matv-news/matv-news-dream-initiatives-forces-of-beauty-report-aafprs-medical-mission-trip-to-ukraine-galdermas-investigational-neurotoxin-gets-high-marks/33706/Allergan Aesthetics and skinbetter science have released a new report from their DREAM Initiative. The Forces of Beauty report provides a new understanding of what inclusive and representative beauty looks like today. Plastic surgeon Kelly Bolden, MD discusses the importance of the findings. AmericaMATV News: Revance’s Daxxify Approved; ASPS Data Show Cosmetic Surgery Booming; DREAM Initiative Supports Residency Curriculum for Advancing Racial Equity
https://modernaesthetics.com/series/matv-news/matv-news-revances-daxxify-approved-asps-data-show-cosmetic-surgery-booming-dream-initiative-supports-residency-curriculum-for-advancing-racial-equity/33703/Revance Therapeutics’ Daxxify (daxibotulinumtoxinA-lanm) wins FDA approval for the temporary improvement of moderate to severe glabellar lines in adults. Clinical trial investigator Jeffrey Dover, MD discusses Daxxify’s unique Peptide Exchange Technology (PXT) and long-lasting effects. New data fromMATV News: Juvéderm Volux XC Approved; Joe Jonas and Xeomin Partner; Breast Implants Recipients Not Following Screening Guidelines
https://modernaesthetics.com/series/matv-news/matv-news-juvederm-volux-xc-approved-joe-jonas-and-xeomin-partner-breast-implants-recipients-not-following-screening-guidelines/33701/Allergan Aesthetics wins FDA approval for Juvéderm Volux XC for the improvement of jawline definition in adults with moderate to severe loss of jawline definition; Pop icon Joe Jonas is the new brand partner for Merz Aesthetics’ Xeomin; and a new study finds silicone breast implant recipients may noMATV News: Promising Data for Galderma's RelabotulinumtoxinA; FDA Approves Sientra's New Breast Implant; Allergan Aesthetics Shares Global Trends Report
https://modernaesthetics.com/series/matv-news/matv-news-promising-data-for-galdermas-relabotulinumtoxina-fda-approves-sientras-new-breast-implant-allergan-aesthetics-shares-global-trends-report/33697/Galderma's investigational RelabotulinumtoxinA, a novel liquid formulation botulinum toxin A, improves glabellar and lateral canthal lines with a rapid onset of action and a long duration up to six months, according to top-line Phase 3 data; and Sientra wins FDA approval for its Low Plus Profile ProMATV News: Plastic Surgery Procedures Soared in 2021; Cosmetic Surgery Benefits; Botox Cosmetic Turns 20
https://modernaesthetics.com/series/matv-news/matv-news-plastic-surgery-procedures-soared-in-2021-cosmetic-surgery-benefits-botox-cosmetic-turns-20/33669/The Aesthetic Society’s annual Aesthetic Plastic Surgery Statistics show plastic surgery procedures were on the rise in 2021. Patients dealing with serious illnesses may want cosmetic procedures to make them look healthier. Botox Cosmetic celebrates 20 years since its first FDA approval.MATV News Extra: AAFPRS 2022 Outlook
https://modernaesthetics.com/series/matv-news/matv-news-extra-aafprs-2022-outlook/33663/Corey S. Maas, MD, President of the American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS), shares his goals for his leadership term. He also discusses the findings of the AAFPRS annual statistics and his insights about what’s driving the current surge in surgical and non-surgical aeMATV News: Thriving in Diversity; Gryphon Acquisition of Revision; Sun Hero Campaign
https://modernaesthetics.com/series/matv-news/matv-news-thriving-in-diversity-gryphon-acquisition-of-revision-sun-hero-campaign/33651/The Thriving in Aesthetics educational series is back for a second season—Thriving in Diversity. Steve Dayan, MD and Sabrina Fabi, MD preview upcoming episodes. Revision Skincare CEO Maria Carell talks about the company’s next steps after its acquisition by Gryphon, and Amy Brodsky, MD wants you toMATV News: Sciton’s BBlink Glasses; Crown to Acquire StriVectin; COVID Impact on Aesthetic Meetings: Galderma Planks for Pink
https://modernaesthetics.com/series/matv-news/matv-news-scitons-bblink-glasses-crown-to-acquire-strivectin-covid-impact-on-aesthetic-meetings-galderma-planks-for-pink/33645/Sciton has introduced new smart goggles designed for provider comfort, Crown Laboratories is set to expand its skincare offerings through acquisition of StriVectin, aesthetic physicians and associations work to make meetings safe amid COVID concerns, and Galderma partners with the National Breast Ca